Drug Type Mesenchymal stem cell therapy |
Synonyms- |
Target- |
Action- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Blindness | Phase 3 | Indonesia | 01 Sep 2023 | |
Retinitis Pigmentosa | Phase 3 | Indonesia | 01 Sep 2023 | |
Infarction | Phase 3 | Indonesia | 01 Jul 2023 | |
ST Elevation Myocardial Infarction | Phase 3 | Indonesia | 01 Jul 2023 | |
Ischemic stroke | Phase 2 | Indonesia | 30 May 2022 | |
Cerebral Palsy | Phase 2 | Indonesia | 13 Oct 2021 | |
Acute myocardial infarction | Phase 2 | Indonesia | 11 Mar 2019 |
Phase 1/2 | 102 | human umbilical cord mesenchymal stem cells | lyfshcrpjg(nlyizuyrea) = bgynnsvfhm pqsefzbdjv (jkfbvawqbh, 69.76) View more | - | 30 Jun 2020 |